Is Resgen overvalued or undervalued?
2025-11-19 08:12:10As of 18 November 2025, the valuation grade for Resgen has moved from fair to very attractive, indicating a significant improvement in its valuation outlook. The company is currently assessed as undervalued. Key ratios supporting this assessment include a PE ratio of 20.29, an EV to EBITDA ratio of 10.32, and a PEG ratio of 0.95, all of which suggest that Resgen is priced favorably compared to its earnings growth potential. In comparison to its peers, Resgen's valuation metrics stand out. For instance, Larsen & Toubro has a much higher PE ratio of 34.3, and CG Power & Industries is deemed very expensive with a PE of 108.1. This places Resgen in a more attractive position relative to its industry, particularly given its solid ROCE of 20.21% and ROE of 12.95%. Despite recent stock performance lagging behind the Sensex, with a year-to-date decline of 33.99% compared to the Sensex's gain of 8.36%, the underlyi...
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
12-Jan-2026 | Source : BSECertificate under Regulation 74(5) of the SEBI (Depository and Participants) Regulations 2018 for the Quarter ended 31st December 2025.
Outcome Of Board Meeting Held For Consideration And Approval Of The Unaudited Financial Results For The Half Year Ended 30Th September 2025
14-Nov-2025 | Source : BSEApproval of the unaudited Financial Results for the half year ended on 30th September 2025
Board Meeting Outcome for Outcome Of Board Meeting Held For Consideration And Approval Of The Unaudited Financial Results For The Half Year Ended 30Th September 2025
14-Nov-2025 | Source : BSEOutcome of Board Meeting held for consideration and approval of the unaudited Financial Results for the half year ended 30th September 2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






